Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KLS-2031 by Kolon Life Science for Radiculopathy: Likelihood of Approval
KLS-2031 is under clinical development by Kolon Life Science and currently in Phase II for Radiculopathy. According to GlobalData, Phase...
Data Insights
KLS-2031 by Kolon Life Science for Neuropathic Pain (Neuralgia): Likelihood of Approval
KLS-2031 is under clinical development by Kolon Life Science and currently in Phase II for Neuropathic Pain (Neuralgia). According to...